The Ca2+/Phospholipid-Binding Proteins of the Submembraneous Skeleton

Author(s):  
Tony Hunter
1992 ◽  
Vol 267 (13) ◽  
pp. 8919-8924
Author(s):  
H Tokumitsu ◽  
A Mizutani ◽  
H Minami ◽  
R Kobayashi ◽  
H Hidaka

Lupus ◽  
2021 ◽  
pp. 096120332199010
Author(s):  
Minerva Gomez-Flores ◽  
Genesis Herrera-Argaez ◽  
Osvaldo Vazquez-Martinez ◽  
Maira Herz-Ruelas ◽  
Jorge Ocampo-Candiani ◽  
...  

Antiphospholipid syndrome (APS) is an acquired thrombophilic disorder in which autoantibodies are produced against a variety of phospholipids and phospholipid-binding proteins. The purpose of this article is to review cutaneous findings in patients with APS diagnosis. An overview regarding prevalence, description, pathogenesis and histopathology, are described for cutaneous manifestations of APS.


2002 ◽  
Vol 59 (9) ◽  
pp. 1467-1477 ◽  
Author(s):  
J. L. Tomsig ◽  
C. E. Creutz

1993 ◽  
Vol 40 (3) ◽  
pp. 281-293 ◽  
Author(s):  
J Bandorowicz ◽  
S Pikuła

1997 ◽  
Vol 89 (6) ◽  
pp. 975-980 ◽  
Author(s):  
C FALCON ◽  
M MARTINUZZO ◽  
R FORASTIERO ◽  
G CERRATO ◽  
L CARRERAS

2004 ◽  
Vol 32 (3) ◽  
pp. 507-510 ◽  
Author(s):  
M. Perretti ◽  
E. Solito

ANXA1 (annexin 1), a member of the ‘annexin’ family of calcium- and phospholipid-binding proteins, was originally identified as an endogenous mediator of the anti-inflammatory actions of glucocorticoids. However, this protein exerts multiple inhibitory effects on the host inflammatory response, including a preferential regulation of the adhesion step of blood-borne neutrophil within the microenvironment of an inflamed vasculature. It is now emerging that ANXA1 is endowed with other roles, since the protein is abundant in inflammatory exudates as it is produced and released by the extravasated neutrophil. In the present paper, we review the novel proapoptotic effect of ANXA1 and discuss its potential with respect to the pathophysiology of inflammation and leucocyte recruitment.


Hematology ◽  
2007 ◽  
Vol 2007 (1) ◽  
pp. 136-142 ◽  
Author(s):  
Jacob H. Rand

Abstract The antiphospholipid syndrome (APS) is an autoimmune thrombophilic condition that is marked by the presence of antibodies that recognize phospholipid-binding proteins. The clinical manifestations of APS include vascular thrombosis and pregnancy complications, especially recurrent spontaneous miscarriages. This article provides an update on diagnostic and therapeutic approaches to this disorder.


FEBS Letters ◽  
1988 ◽  
Vol 233 (2) ◽  
pp. 233-238 ◽  
Author(s):  
Catherine M. Boustead ◽  
John H. Walker ◽  
Michael J. Geisow

Sign in / Sign up

Export Citation Format

Share Document